Antonius Timotheus Otten (Antonius T Otten)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 8

Top Topics

Placebo Controlled

Top Venues

Inflammatory bowel diseases

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Antonius Timotheus Otten, Hedwig H van der Meulen, Maurice Steenhuis, Floris C Loeff, Daniel J Touw, Jos G W Kosterink, Henderik W Frijlink, Theo Rispens, Gerard Dijkstra, Marijn C Visschedijk, Arno R Bourgonje
Clinical Validation of a Capillary Blood Home-Based Self-Sampling Technique for Monitoring of Infliximab, Vedolizumab, and C-Reactive Protein Concentrations in Patients With Inflammatory Bowel Disease. Inflammatory bowel diseases (2023)
Antonius Timotheus Otten, Gerard Dijkstra, Marijn C Visschedijk, Arno R Bourgonje
The Future of Therapeutic Drug Monitoring in Inflammatory Bowel Disease: An Emphasis on the Essential Ingredients. Inflammatory bowel diseases (2023)
Antonius Timotheus Otten, V Peters, I Barth, C L Stevens, Arno R Bourgonje, H W Frijlink, H J M Harmsen, A Rehman, M J E Campmans-Kuijpers, G Dijkstra
Effects of ileocolonic delivered vitamin B 2 , B 3 and C (ColoVit) or the Groningen anti-inflammatory diet on disease course and microbiome of patients with Crohn's disease (VITA-GrAID study): a protocol for a randomised and partially blinded trial. BMJ open 13 (3) (2023)
Antonius Timotheus Otten, V Peters, I Barth, C L Stevens, Arno R Bourgonje, H W Frijlink, H J M Harmsen, A Rehman, M J E Campmans-Kuijpers, G Dijkstra
Effects of ileocolonic delivered vitamin B 2 , B 3 and C (ColoVit) or the Groningen anti-inflammatory diet on disease course and microbiome of patients with Crohn's disease (VITA-GrAID study): a protocol for a randomised and partially blinded trial. BMJ open 13 (3) (2023)
Antonius Timotheus Otten, V Peters, I Barth, C L Stevens, Arno R Bourgonje, H W Frijlink, H J M Harmsen, A Rehman, M J E Campmans-Kuijpers, G Dijkstra
Effects of ileocolonic delivered vitamin B 2 , B 3 and C (ColoVit) or the Groningen anti-inflammatory diet on disease course and microbiome of patients with Crohn's disease (VITA-GrAID study): a protocol for a randomised and partially blinded trial. BMJ open 13 (3) (2023)
Adrianus M van der Holst, Antonius Timotheus Otten, Elise M Meima-van Praag, Alexander R P K M van Renterghem, Arno R Bourgonje, Ellen S van Loo, Gerard Dijkstra, Christianne J Buskens, Laurents P S Stassen
Temporary diverting stoma in therapy-refractory luminal colonic Crohn's disease: an alternative to immediate colorectal resection? Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2023)
Aisha A Ahmed, Antonius Timotheus Otten, Bahez Gareb, Judith E Huijmans, Anko C Eissens, Ateequr Rehman, Gerard Dijkstra, Jos G W Kosterink, Henderik W Frijlink, Reinout C A Schellekens
Capsules with Ileocolonic-Targeted Release of Vitamin B 2 , B 3 , and C (ColoVit) Intended for Optimization of Gut Health: Development and Validation of the Production Process. Pharmaceutics 15 (5) (2023)
Arno R Bourgonje, Marta Sorokina Alexdottir, Antonius Timotheus Otten, Roberta Loveikyte, Anne Christine Bay-Jensen, Martin Pehrsson, Hendrik M van Dullemen, Marijn C Visschedijk, Eleonora A M Festen, Rinse K Weersma, Morten Asser Karsdal, Klaas Nico Faber, Joachim Høg Mortensen, Gerard Dijkstra
Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohn's disease. Alimentary pharmacology & therapeutics 56 (4) (2022)